propiolattone
Approved
Jun 12, 1959
Propiolactone (or beta-propiolactone) is a disinfectant used in vapor form to sterilize vaccines, grafts, blood plasma, surgical instruments. It has been used against bacteria, fungi, and virus. Propiolactone was first commercially available in the United States in 1958 but then was withdrawn because it was discovered that compound was a human carcinogen. The results have shown the generation of tumors in several tissues and from different administration routes. Propiolactone is a direct-acting alkylating agent that reacts with polynucleotides and DNA, mainly at N7 of guanine and N1 of adenine, to form carboxyethyl derivatives. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Timeline
1950s
- Jun 12, 1959
Forest Laboratories — Earliest FDA Approval
- Jun 12, 1959
Forest Laboratories — NDA Secondary Org
- Jun 12, 1959
Forest Laboratories — NDA Organization
Indications
Approved for
Mechanism of action
- DNACROSS-LINKING AGENT
DNA cross-linking agent
Approval history
- approvedJun 12, 1959
Chemistry & pharmacology
SMILES
O=C1CCO1- Mol. weight
- 72.0627 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Availability
- Discontinued
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS6RC3ZT4HB0 ↗
- ChEMBLCHEMBL1200627 ↗
Also known as
- 1,3-propiolactone
- 2-oxetanone
- betaprone
- betaprone
- betaprone
- betaprone
- betaprone
- betaprone
- beta-propiolactone
- beta-propiolactone
- beta-propiolactone
- hydracrylic acid beta-lactone
- propanolide
- propiolactone
- propiolactone
- propiolactone
- propiolactone
- propiolactone
- propiolactone
- propiolattone
- β-propiolactone
- β-propiolactone
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Forest Laboratories | For profit | NDA2 | Jun 12, 1959 |
| Forest Laboratories | For profit | NDA | Jun 12, 1959 |